ANG Lifesciences India Ltd vs SUN PHARMACEUTICAL IND L
A side-by-side comparison of ANG Lifesciences India Ltd (ANG) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, SUN PHARMACEUTICAL IND L leads ANG vs SUNPHARMA on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation31
- Profitability04
- Growth01
- Size & financial health04
Valuation
ANG takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
SUNPHARMA takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
SUNPHARMA takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Stock is trading at 0.93 times its book value"]
- − ["The company has delivered a poor sales growth of -9.6% over past five years.", "Company has a low return on equity of -16.4% over last 3 years.", "Company reported a net loss of ₹11 Cr in its latest financial year."]
- + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
- − ["Stock is trading at 5.00 times its book value"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.